Indegene Limited (NSE:INDGN)

Market Cap	132.53B
Revenue (ttm)	28.39B
Net Income (ttm)	4.07B
Shares Out	239.27M
EPS (ttm)	17.02
PE Ratio	32.54
Forward PE	27.74
Dividend	2.00 (0.37%)
Ex-Dividend Date	n/a

Volume	163,798
Average Volume	275,511
Open	541.00
Previous Close	544.60
Day's Range	538.20 - 556.00
52-Week Range	470.10 - 736.30
Beta	n/a
RSI	48.47
Earnings Date	Apr 28, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,367
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.